Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 69,582 shares at $45.53 ($3.2M) on 2026-03-23, disclosed to the SEC on 2026-03-25.
Scheduled sale ($3.2M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.53 | 1,875 | $85K | 2.7% |
| 2 | $45.53 | 32,916 | $1.5M | 47.3% |
| 3 | $45.53 | 1,875 | $85K | 2.7% |
| 4 | $45.53 | 32,916 | $1.5M | 47.3% |
| Total | $45.53 avg | 69,582 | $3.2M | 100% |
| Filing → |
| RPRX | SELL | 2026-04-30 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-04 | $3.3M | — | Filing → |